All lobbying filings

ALSTON & BIRD LLP

Lobbying for CURIE BIO OPERATIONS, LLC · Venture Capital Firm and Biotech Accelerator

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$150,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.

Banking

FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.

Budget/Appropriations

FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.

Financial Institutions/Investments/Securities

FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.

Bills named in this filing 2

H.R. 9102
BINSA Act
S. 5316
BINSA Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.